Chairman of PharmExcil (Pharmaceuticals Export Promotion Council of India) Veeramani S V said the Indian pharmaceutical industry is on a co...

The Competition Commission of India (CCI) has approved the acquisition of additional Series E compulsorily convertible preference shares of...

Platinum Owl is acting in its capacity as a trustee for Platinum Jasmine A 2018 Trust and Abu Dhabi Investment Authority (ADIA) is the sole...

The initial share sale comprises a fresh issue of equity shares aggregating up to Rs 450 crore, with a face value of Rs 5 each and an offer...

The Indian pharmaceutical industry, with current market size of USD 27.57 billion is expected to reach USD 55 billion by 2020 growing at a ...

ET’s weekly roundup of the wackiest whispers and murmurs in corporate corridors and policy parlours.

The 10th edition of CPhI India, which is touted as South Asia's largest pharma event will take place between November 21 and 23.

The 10th edition of CPhI India, which is touted as South Asia's largest pharma event will take place between November 21 and 23.

The Indian bulk drug industry is in dire straits and their prospects appear bleak unless the government takes immediate steps to support th...

Participation of Indian firms is expected to increase awareness about the domestic pharmaceutical industry amongst the global stakeholders.

The government and major pharmaceutical industry organisations have come together to form the 'India-Responsible Healthcare Trust'.

Analysts say the timing to promote Indian generics globally is just right as the next three years will be crucial in terms of opportunity.

ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.

In a show of solidarity, hotel companies like Hyatt, Mariott, ITC, Four Seasons and The Leela have approached the Oberoi-Trident and Taj to...